[{"id":"79d4d4ea-aa9e-4b6e-99bb-a75bd6f50614","acronym":"","url":"https://clinicaltrials.gov/study/NCT05573035","created_at":"2022-10-10T14:05:28.455Z","updated_at":"2024-07-02T16:34:26.946Z","phase":"Phase 1","brief_title":"A Study to Investigate LYL845 in Adults With Solid Tumors","source_id_and_acronym":"NCT05573035","lead_sponsor":"Lyell Immunopharma, Inc.","biomarkers":" BRAF • MSI","pipe":" | ","alterations":" MSI-H/dMMR • BRAF mutation","tags":["BRAF • MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR • BRAF mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LYL845"],"overall_status":"Recruiting","enrollment":" Enrollment 108","initiation":"Initiation: 12/19/2022","start_date":" 12/19/2022","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 09/01/2027","study_completion_date":" 09/01/2027","last_update_posted":"2024-06-12"}]